vs
IRIDEX CORP（IRIX）与SuperCom Ltd（SPCB）财务数据对比。点击上方公司名可切换其他公司
IRIDEX CORP的季度营收约是SuperCom Ltd的1.0倍（$14.7M vs $14.2M），SuperCom Ltd同比增速更快（-1.5% vs -69.7%）
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
Super.com是一家总部位于美国旧金山的科技公司，由侯赛因·法扎勒和施亨利联合创立。该公司主营金融服务业务，具体涵盖会员奖励计划以及旅行预订等相关服务，在出行与消费金融领域深耕发展。
IRIX vs SPCB — 直观对比
营收规模更大
IRIX
是对方的1.0倍
$14.2M
营收增速更快
SPCB
高出68.3%
-69.7%
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.7M | $14.2M |
| 净利润 | — | $5.3M |
| 毛利率 | 37.2% | 61.2% |
| 营业利润率 | — | 16.3% |
| 净利率 | — | 37.5% |
| 营收同比 | -69.7% | -1.5% |
| 净利润同比 | — | 79.5% |
| 每股收益（稀释后） | — | $1.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRIXSPCB
| Q4 25 | $14.7M | — | ||
| Q3 25 | $12.5M | — | ||
| Q2 25 | $13.6M | $14.2M | ||
| Q1 25 | $11.9M | — | ||
| Q4 24 | $12.7M | — | ||
| Q3 24 | $11.6M | — | ||
| Q2 24 | $12.6M | $14.4M | ||
| Q1 24 | $11.8M | — |
净利润IRIXSPCB
| Q4 25 | — | — | ||
| Q3 25 | $-1.6M | — | ||
| Q2 25 | $-994.0K | $5.3M | ||
| Q1 25 | $-1.7M | — | ||
| Q4 24 | $-834.0K | — | ||
| Q3 24 | $-1.9M | — | ||
| Q2 24 | $-2.7M | $3.0M | ||
| Q1 24 | $-3.5M | — |
毛利率IRIXSPCB
| Q4 25 | 37.2% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 34.5% | 61.2% | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | 44.0% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 40.7% | 52.3% | ||
| Q1 24 | 37.9% | — |
营业利润率IRIXSPCB
| Q4 25 | — | — | ||
| Q3 25 | -11.3% | — | ||
| Q2 25 | -6.9% | 16.3% | ||
| Q1 25 | -1.7% | — | ||
| Q4 24 | -3.9% | — | ||
| Q3 24 | -16.1% | — | ||
| Q2 24 | -20.9% | 7.7% | ||
| Q1 24 | -28.0% | — |
净利率IRIXSPCB
| Q4 25 | — | — | ||
| Q3 25 | -12.6% | — | ||
| Q2 25 | -7.3% | 37.5% | ||
| Q1 25 | -14.2% | — | ||
| Q4 24 | -6.6% | — | ||
| Q3 24 | -16.7% | — | ||
| Q2 24 | -21.2% | 20.6% | ||
| Q1 24 | -29.5% | — |
每股收益（稀释后）IRIXSPCB
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.06 | $1.32 | ||
| Q1 25 | $-0.10 | — | ||
| Q4 24 | $-0.05 | — | ||
| Q3 24 | $-0.12 | — | ||
| Q2 24 | $-0.16 | $1.19 | ||
| Q1 24 | $-0.21 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.0M | $15.0M |
| 总债务越低越好 | — | $23.6M |
| 股东权益账面价值 | — | $37.3M |
| 总资产 | $29.2M | $65.5M |
| 负债/权益比越低杠杆越低 | — | 0.63× |
8季度趋势，按日历期对齐
现金及短期投资IRIXSPCB
| Q4 25 | $6.0M | — | ||
| Q3 25 | $5.6M | — | ||
| Q2 25 | $6.8M | $15.0M | ||
| Q1 25 | $7.2M | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $3.9M | — | ||
| Q2 24 | $4.1M | $5.7M | ||
| Q1 24 | $5.4M | — |
总债务IRIXSPCB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $23.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.0M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | — | $29.2M | ||
| Q1 24 | — | — |
股东权益IRIXSPCB
| Q4 25 | — | — | ||
| Q3 25 | $4.7M | — | ||
| Q2 25 | $6.1M | $37.3M | ||
| Q1 25 | $852.0K | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.6M | — | ||
| Q2 24 | $4.2M | $13.8M | ||
| Q1 24 | $6.5M | — |
总资产IRIXSPCB
| Q4 25 | $29.2M | — | ||
| Q3 25 | $28.4M | — | ||
| Q2 25 | $31.6M | $65.5M | ||
| Q1 25 | $34.2M | — | ||
| Q4 24 | $29.1M | — | ||
| Q3 24 | $30.2M | — | ||
| Q2 24 | $31.2M | $49.6M | ||
| Q1 24 | $34.1M | — |
负债/权益比IRIXSPCB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | — | 2.11× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-2.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-3.6M |
| 自由现金流率自由现金流/营收 | — | -25.3% |
| 资本支出强度资本支出/营收 | — | 10.0% |
| 现金转化率经营现金流/净利润 | — | -0.41× |
| 过去12个月自由现金流最近4个季度 | — | $-14.0M |
8季度趋势，按日历期对齐
经营现金流IRIXSPCB
| Q4 25 | — | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $-397.0K | $-2.2M | ||
| Q1 25 | $-1.1M | — | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-3.1M | — | ||
| Q2 24 | $-1.3M | $-950.0K | ||
| Q1 24 | $-1.6M | — |
自由现金流IRIXSPCB
| Q4 25 | — | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $-410.0K | $-3.6M | ||
| Q1 25 | $-1.2M | — | ||
| Q4 24 | $-1.2M | — | ||
| Q3 24 | $-3.1M | — | ||
| Q2 24 | — | $-1.6M | ||
| Q1 24 | $-1.7M | — |
自由现金流率IRIXSPCB
| Q4 25 | — | — | ||
| Q3 25 | -9.4% | — | ||
| Q2 25 | -3.0% | -25.3% | ||
| Q1 25 | -9.8% | — | ||
| Q4 24 | -9.8% | — | ||
| Q3 24 | -26.5% | — | ||
| Q2 24 | — | -10.8% | ||
| Q1 24 | -14.0% | — |
资本支出强度IRIXSPCB
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.1% | 10.0% | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | 4.2% | ||
| Q1 24 | 0.0% | — |
现金转化率IRIXSPCB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.41× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.32× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
